Charles L. Bowden
#121,241
Most Influential Person Now
Charles L. Bowden's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Charles L. Bowden Influential?
(Suggest an Edit or Addition)Charles L. Bowden's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Journal of Neuropsychiatry and Clinical Neurosciences (1992) (1063)
- A double- Blind placebo-controlled study of lamotriqine monotherapy outpatients with bipolar I depression (1999) (842)
- Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. (2003) (819)
- Effectiveness of adjunctive antidepressant treatment for bipolar depression. (2007) (817)
- Long-Term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD) (2004) (814)
- Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania (1994) (811)
- Practice guideline for the treatment of patients with bipolar disorder (revision). (2002) (751)
- Oral topiramate for treatment of alcohol dependence: a randomised controlled trial (2003) (717)
- A Randomized, Placebo-Controlled 12-Month Trial of Divalproex and Lithium in Treatment of Outpatients With Bipolar I Disorder (2000) (643)
- A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. (2003) (626)
- Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. (1994) (599)
- A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. (2003) (590)
- The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. (2013) (551)
- Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD) (2003) (499)
- A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder (2000) (446)
- Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. (2002) (418)
- Depression during mania. Treatment response to lithium or divalproex. (1997) (408)
- Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. (2002) (391)
- The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. (2009) (388)
- Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study. (2011) (373)
- The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder (2013) (360)
- A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. (2004) (360)
- Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. (2001) (355)
- The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression (2010) (348)
- The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. (2005) (335)
- Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. (2005) (332)
- The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania (2009) (331)
- A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. (2005) (329)
- A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. (1999) (313)
- CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis. (1983) (308)
- Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. (2006) (294)
- Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. (2009) (293)
- Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone (2004) (288)
- Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double‐blind, randomized, placebo‐controlled study (2008) (275)
- Strategies to reduce misdiagnosis of bipolar depression. (2001) (259)
- Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. (2009) (242)
- Onset and Early Behavioral Effects of Pharmacologically Different Antidepressants and Placebo in Depression (2004) (241)
- Aripiprazole Monotherapy in Nonpsychotic Bipolar I Depression: Results of 2 Randomized, Placebo-Controlled Studies (2008) (235)
- Comorbidity of migraine and major affective disorders (1994) (232)
- Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. (1999) (232)
- The Neurocognitive Signature of Psychotic Bipolar Disorder (2007) (228)
- Trait impulsivity in patients with mood disorders. (2007) (211)
- A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. (2000) (210)
- A different depression: clinical distinctions between bipolar and unipolar depression. (2005) (195)
- Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. (2007) (189)
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Bipolar Disorders, Part I: Treatment of Bipolar Depression (2002) (186)
- The World Federation of Socleties of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania (2003) (176)
- Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. (1999) (173)
- Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. (2002) (169)
- The timing, specificity and clinical prediction of tricyclic drug effects in depression (1987) (168)
- Maintenance Efficacy of Divalproex in the Prevention of Bipolar Depression (2003) (160)
- Atypical antipsychotics in bipolar depression: potential mechanisms of action. (2005) (159)
- An open-label trial of divalproex in children and adolescents with bipolar disorder. (2002) (153)
- The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part III: Maintenance Treatment (2004) (152)
- ECNP consensus meeting. Bipolar depression. Nice, March 2007 (2008) (151)
- Relation of serum valproate concentration to response in mania. (1996) (147)
- Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. (2009) (145)
- Bipolar Depression: Overview and Commentary (2010) (145)
- Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study. (2015) (141)
- The efficacy of lamotrigine in rapid cycling and non–rapid cycling patients with bipolar disorder (1999) (140)
- A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. (2000) (135)
- Fluoxetine: A Serotonin‐specific, Second‐generation Antidepressant (1987) (133)
- Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. (2004) (133)
- Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants. (2001) (132)
- Does recovery from substance use disorder matter in patients with bipolar disorder? (2005) (131)
- Pattern of Response to Divalproex, Lithium, or Placebo in Four Naturalistic Subtypes of Mania (2002) (131)
- Bipolar rapid cycling: focus on depression as its hallmark. (2001) (131)
- Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: A call to action (2004) (131)
- Predictors of response to divalproex and lithium. (1995) (130)
- Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. (2002) (129)
- Early Administration of Reteplase Plus Abciximab vs Abciximab Alone in Patients With Acute Myocardial Infarction Referred for Percutaneous Coronary Intervention (2004) (121)
- Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial. (2010) (117)
- Neuronal Correlates of Brain-derived Neurotrophic Factor Val66Met Polymorphism and Morphometric Abnormalities in Bipolar Disorder (2009) (115)
- Effects of carbamazepine on plasma haloperidol levels. (1985) (112)
- National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. (2002) (112)
- The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder (2018) (109)
- A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. (2006) (107)
- Specificity of mixed affective states: clinical comparison of dysphoric mania and agitated depression. (1993) (105)
- Safety and Tolerability of Lamotrigine for Bipolar Disorder (2004) (98)
- Hypothalamic‐pituitary‐adrenocortical function in mixed and pure mania (1992) (95)
- Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania. (2006) (94)
- Divalproex in the Treatment of Posttraumatic Stress Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial in a Veteran Population (2008) (94)
- Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes (2012) (91)
- Suicide attempts in major depressive episode: evidence from the BRIDGE‐II‐Mix study (2015) (90)
- Sources of declarative memory impairment in bipolar disorder: mnemonic processes and clinical features. (2006) (89)
- Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs. (1984) (88)
- Development of the Bipolar Inventory of Symptoms Scale (2007) (87)
- Catecholamine metabolism and disposition in healthy and depressed subjects. (1987) (85)
- Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder. (2013) (84)
- Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder. (2006) (84)
- Factors associated with stigma among caregivers of patients with bipolar disorder in the STEP-BD study. (2007) (81)
- Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin. (1988) (81)
- Depression during mania (1997) (80)
- Influence of sub-syndromal symptoms after remission from manic or mixed episodes (2006) (79)
- Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. (2008) (78)
- Task Force on Treatment Guidelines for Bipolar Disorders (2002) (78)
- Temperament and character traits in patients with bipolar disorder and associations with comorbid alcoholism or anxiety disorders. (2008) (78)
- New Concepts in Mood Stabilization: Evidence for the Effectiveness of Valproate and Lamotrigine (1998) (77)
- Lamotrigine in the treatment of bipolar depression (1999) (76)
- Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes (2008) (75)
- Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment (1982) (74)
- Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). (2015) (73)
- Biological component of the NIMH Clinical Research Branch Collaborative Program on the psychobiology of depression: I. Background and theoretical considerations (1980) (71)
- Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia (1986) (69)
- Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group. (1997) (67)
- Evidence-based definitions of bipolar-I and bipolar-II disorders among 5,635 patients with major depressive episodes in the Bridge Study: validity and comorbidity (2013) (67)
- Key treatment studies of lithium in manic-depressive illness: efficacy and side effects. (1998) (66)
- Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling. (2003) (66)
- Reduced educational attainment in bipolar disorder. (2006) (66)
- Identifying features of bipolarity in patients with first-episode postpartum depression: findings from the international BRIDGE study. (2012) (64)
- Studies of Catecholamine Metabolism in Schizophrenia/Psychosis-I (1993) (64)
- Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. (2013) (63)
- Practice guideline for the treatment of patients with bipolar disorder, second edition. (2002) (63)
- Fluoxetine and desipramine in major depressive disorder. (1993) (62)
- Effect of comorbid anxiety on treatment response in bipolar depression. (2007) (62)
- Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder. (2006) (62)
- Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder. (2016) (61)
- Journal of Nervous and Mental Disease, The (2007) (61)
- Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials. (2006) (60)
- Depressive mania versus agitated depression: Biogenic amine and hypothalamic-pituitary-adrenocortical function (1994) (60)
- Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): A pragmatic trial of complex treatment for a complex disorder (2014) (60)
- Double-blind comparison of buspirone and clorazepate in anxious outpatients. (1986) (59)
- Efficacy of lithium in mania and maintenance therapy of bipolar disorder. (2000) (59)
- Aims and Results of the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP‐BD) (2012) (59)
- Effects of lithium on platelet ionic intracellular calcium concentration in patients with bipolar (manic-depressive) disorder and healthy controls. (1990) (56)
- Maintenance clinical trials in bipolar disorder: design implications of the divalproex-lithium-placebo study. (1997) (56)
- Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid (1985) (56)
- Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression. (1990) (54)
- Bipolar disorder and work loss. (2005) (53)
- Anticonvulsants in bipolar disorders: current research and practice and future directions. (2009) (53)
- Poor quality of life and functioning in bipolar disorder (2017) (53)
- Calcium function in affective disorders and healthy controls (1988) (52)
- Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder. (2005) (52)
- Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression (1999) (51)
- Plasma dopamine-beta-hydroxylase and platelet monoamine oxidase in attention deficit disorder and conduct disorder. (1988) (51)
- Clinical correlates of therapeutic response in bipolar disorder. (2001) (50)
- Association of psychosis with suicidality in pediatric bipolar I, II and bipolar NOS patients. (2006) (49)
- Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial (2010) (49)
- The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine. (1994) (49)
- Relationship of Mania Symptomatology to Maintenance Treatment Response with Divalproex, Lithium, or Placebo (2005) (49)
- Role of Newer Medications for Bipolar Disorder (1996) (48)
- Plasma GABA predicts acute response to divalproex in mania (1996) (47)
- Serotonin gene polymorphisms and bipolar I disorder: Focus on the serotonin transporter (2005) (46)
- Kinetic Characterization of Ca2+ Transport in Synaptic Membranes (1981) (46)
- Anterior cingulate volumes associated with trait impulsivity in individuals with bipolar disorder. (2009) (45)
- Is there a metabolic basis for the fibrositis syndrome? (1986) (45)
- Development of the Bipolar Inventory of Symptoms Scale: concurrent validity, discriminant validity and retest reliability (2008) (45)
- Plasma and erythrocyte electrolytes in affective disorders. (1983) (44)
- Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder. (2009) (44)
- Antidepressant-induced hypomania/mania in patients with major depression: Evidence from the BRIDGE-II-MIX study. (2017) (43)
- Rethinking depression and the actions of antidepressants: uncovering the links between the neural and behavioral elements. (2010) (43)
- Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence. (2008) (43)
- Acute and maintenance treatment with mood stabilizers. (2003) (43)
- Is comorbid borderline personality disorder in patients with major depressive episode and bipolarity a developmental subtype? Findings from the international BRIDGE study. (2013) (42)
- Contributors to suicidal ideation among bipolar patients with and without a history of suicide attempts. (2005) (41)
- Effects of debrisoquin on CSF and plasma HVA concentrations in man. (1985) (41)
- Depressive relapse during lithium treatment associated with increased serum thyroid‐stimulating hormone: results from two placebo‐controlled bipolar I maintenance studies (2009) (41)
- Psychomotor performance and monoamine function in bipolar and unipolar affective disorders (1999) (40)
- Maintenance therapies for classic and other forms of bipolar disorder. (2000) (40)
- Identifying the specific clinical actions of amitriptyline: interrelationships of behaviour, affect and plasma levels in depression (1991) (40)
- Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls. (1988) (40)
- The bipolar–borderline personality disorders connection in major depressive patients (2013) (40)
- ECNP consensus meeting March 2000: Nice guidelines for investigating efficacy in bipolar disorder (2001) (39)
- Making optimal use of combination pharmacotherapy in bipolar disorder. (2004) (39)
- Drug-Induced Actions on Brain Neurotransmitter Systems and Changes in the Behaviors and Emotions of Depressed Patients (1994) (39)
- Safety and Efficacy of Long‐term Diazepam Therapy (1980) (38)
- Are bipolar disorders underdiagnosed in patients with depressive episodes? Results of the multicenter BRIDGE screening study in Germany. (2012) (38)
- Lithium treatment — moderate dose use study (LiTMUS) for bipolar disorder: rationale and design (2009) (38)
- Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder. (2004) (38)
- Effect size of efficacy measures comparing divalproex, lithium and placebo in acute mania (1997) (38)
- Bupropion slow-release response in depression: diagnosis and biochemistry (1998) (38)
- A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode (2008) (38)
- Spectrum of effectiveness of valproate in neuropsychiatry (2007) (38)
- Attention deficits in bipolar disorder: a comparison based on the Continuous Performance Test (2005) (38)
- Safety and tolerability associated with second-generation antipsychotic polytherapy in bipolar disorder: findings from the Systematic Treatment Enhancement Program for Bipolar Disorder. (2011) (37)
- Six-Month Prospective Life Charting of Mood Symptoms with Lamotrigine Monotherapy Versus Placebo in Rapid Cycling Bipolar Disorder (2008) (36)
- Principal domains of behavioral psychopathology identified by the Bipolar Inventory of Signs and Symptoms Scale (BISS) (2010) (36)
- Dosing strategies and time course of response to antimanic drugs. (1996) (35)
- Novel treatments for bipolar disorder (2001) (35)
- Patterns of response to antidepressants in major depressive disorder: Drug resistance or worsening of depression are associated with a bipolar diathesis (2019) (35)
- Obesity in patients with major depression is related to bipolarity and mixed features: evidence from the BRIDGE‐II‐Mix study (2017) (35)
- Natural killer cell activity in major depression. (1987) (35)
- Transcultural validity of the Hypomania Checklist–32 (HCL‐32) in patients with major depressive episodes (2013) (35)
- Imipramine and Amitriptyline Plasma Concentrations and Clinical Response in Major Depression (1986) (34)
- A follow-up study of narcotic addicts in the NARA program. (1971) (33)
- Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS) (2013) (33)
- The expert consensus guideline series (2009) (32)
- Diagnosis, treatment, and recovery maintenance in bipolar depression. (2010) (32)
- A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR). (2015) (31)
- Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study. (2009) (30)
- Treatment options for bipolar depression. (2005) (30)
- Current Topics in Behavioral Neurosciences (2011) (29)
- Valproate for bipolar disorder. (1994) (29)
- Lamotrigine in the treatment of bipolar disorder (2002) (29)
- Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms (2012) (29)
- Brain-derived neurotrophic factor val66met polymorphism affects prefrontal energy metabolism in bipolar disorder (2007) (29)
- Illness characteristics of patients in clinical drug studies of mania. (1995) (28)
- Adrenomedullary function in depressed patients. (1994) (28)
- Bipolar pathophysiology and development of improved treatments (2008) (28)
- Schizophrenia, psychosis, and cerebral spinal fluid homovanillic acid concentrations. (1997) (27)
- Mental health attitudes and treatment expectations as treatment variables. (1980) (27)
- Incorporation of [3H]valproic acid into lipids in GT1-7 neurons. (1998) (27)
- Diagnosing manic-depressive illness in adolescents. (1980) (27)
- Is recurrence in major depressive disorder related to bipolarity and mixed features? Results from the BRIDGE-II-Mix study. (2018) (27)
- P.1.091 Olanzapine's efficacy for relapse prevention in bipolar disorder: A randomized double-blind placebo-controlled 12-month clinical trial (2003) (27)
- P.1.092 Olanzapine versus lithium in relapse prevention in bipolar disorder: A randomized double-blind controlled 12-month clinical trial (2003) (27)
- Dopamine-beta-hydroxylase in behaviorally disturbed youth Relationship between teacher and parent ratings (1993) (27)
- A multivantaged behavioural method for measuring onset and sequence of the clinical actions of antidepressants. (2004) (26)
- Suicidal ideation and pharmacotherapy among STEP-BD patients. (2005) (26)
- Trait Impulsivity Is Increased in Bipolar Disorder Patients with Comorbid Alcohol Use Disorders (2012) (25)
- A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania. (2010) (25)
- Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism (2010) (24)
- Bipolar Medications: Mechanisms of Action (2000) (24)
- Sertraline and isocarboxazid cause a serotonin syndrome. (1994) (23)
- History of the development of valproate for treatment of bipolar disorder. (1995) (23)
- Integrated transcriptome and methylome analysis in youth at high risk for bipolar disorder: a preliminary analysis (2017) (23)
- White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder (2017) (23)
- Kinetic characterization and substrate requirement for the Ca2+ uptake system in platelet membrane. (1982) (22)
- Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study. (2016) (22)
- Mania: Sympathoadrenal function and clinical state (1991) (22)
- Psychotherapy use in bipolar disorder: Association with functioning and illness severity (2015) (21)
- Acute effects of neuroleptics on unmedicated schizophrenic patients and controls (1993) (21)
- Treatment characteristics and illness burden among European Americans, African Americans, and Latinos in the first 2,000 patients of the systematic treatment enhancement program for bipolar disorder. (2007) (21)
- Sensation seeking in psychiatrically disturbed youth: relationship to biochemical parameters and behavior problems. (1994) (21)
- The role of overlapping excitatory symptoms in major depression: are they relevant for the diagnosis of mixed state? (2019) (20)
- Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD. (2004) (20)
- Complexity of Illness and Adjunctive Benzodiazepine Use in Outpatients With Bipolar I or II Disorder: Results From the Bipolar CHOICE Study (2015) (20)
- Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium. (2007) (19)
- A survey of information sources used by psychiatrists. (1971) (19)
- Lamotrigine vs. lamotrigine plus divalproex in randomized, placebo‐controlled maintenance treatment for bipolar depression (2012) (18)
- Delusional misidentification of the self associated with nondominant cerebral pathology. (1995) (18)
- Treatment of bipolar depression (1998) (18)
- A factor analytic study in bipolar depression, and response to lamotrigine (2013) (18)
- Relationship between serum valproate and lithium levels and efficacy and tolerability in bipolar maintenance therapy (2005) (18)
- Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial. (2018) (17)
- 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard. (1984) (17)
- Enhancing the Technology of Clinical Trials and the Trials Model to Evaluate Newly Developed, Targeted Antidepressants (2002) (17)
- Lamotrigine (Lamictal IR) for the treatment of bipolar disorder (2012) (17)
- A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report. (2016) (17)
- Clonidine plus haloperidol in the treatment of schizophrenia/psychosis. (1995) (17)
- Platelet monoamine oxidase response to lithium treatment in psychiatric patients. (1984) (16)
- Pharmacotherapy for bipolar depression: an economic assessment (2004) (16)
- One-year treatment outcomes of African-American and Hispanic patients with bipolar I or II disorder in STEP-BD. (2010) (16)
- Anticonvulsants in Bipolar Disorder (2006) (16)
- Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes. (2011) (16)
- Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial. (2014) (16)
- The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorder. (2014) (16)
- The ability of lithium and other mood stabilizers to decrease suicide risk and prevent relapse (2000) (16)
- Linkage disequilibrium mapping of the chromosome 6q21–22.31 bipolar I disorder susceptibility locus (2009) (15)
- Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder. (2017) (15)
- Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder (2017) (15)
- The Medication Recommendation Tracking Form: a novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research. (2013) (15)
- A cognitive model of dangerous delusional misidentification syndromes. (1994) (15)
- Tricyclic antidepressant washout effects on cerebrospinal fluid and urinary monoamine and metabolites. (1986) (15)
- Clinical correlates of acute bipolar depressive episode with psychosis. (2017) (15)
- Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder. (2008) (15)
- Goals of medical student psychiatric education. (1975) (14)
- Discriminating primary clinical states in bipolar disorder with a comprehensive symptom scale (2013) (14)
- Cerebrospinal fluid levels of amitriptyline, nortriptyline, imipramine and desmethylimipramine. Relationship to plasma levels and treatment outcome. (1985) (14)
- Homovanillic acid and monoamine oxidase in sons of substance-abusing fathers: relationship to conduct disorder. (1995) (14)
- Pharmacological Treatment of Bipolar Disorder (2002) (14)
- The impact of binge eating behavior on lithium- and quetiapine-associated changes in body weight, body mass index, and waist circumference during 6 months of treatment: Findings from the bipolar CHOICE study. (2020) (14)
- Lithium and impairment of renal concentrating ability. (1985) (14)
- Relationship of diazepam serum level to antianxiety effects. (1982) (13)
- Sultans of Swing: A Reappraisal of the Intertwined Association Between Affective Lability and Mood Reactivity in a Post Hoc Analysis of the BRIDGE-II-MIX Study. (2019) (13)
- The effectiveness of divalproate in all forms of mania and the broader bipolar spectrum: many questions, few answers. (2004) (13)
- Multi-state outcome analysis of treatments (MOAT): application of a new approach to evaluate outcomes in longitudinal studies of bipolar disorder (2015) (13)
- Urine and plasma levels of dopamine metabolites in response to apomorphine and neuroleptics in schizophrenics (1988) (12)
- A correlation between dropout status and improvement in a psychiatric clinic. (1980) (12)
- Distinct lithium-induced gene expression effects in lymphoblastoid cell lines from patients with bipolar disorder (2017) (12)
- Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment – Moderate dose Use Study (LiTMUS) for bipolar disorder (2012) (12)
- Bipolar depression and suicidal ideation: Moderators and mediators of a complex relationship. (2019) (12)
- Success and failure in the NARA addiction program. (1972) (12)
- Pretreatment amine neurotransmitter system interrelationships in depression [proceedings]. (1981) (12)
- Symptom networks in acute depression across bipolar and major depressive disorders: A network analysis on a large, international, observational study (2020) (12)
- Thioridazine-induced retinopathy. (1996) (12)
- Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale. (2019) (12)
- Resolving the onset of antidepressants' clinical actions: critical for clinical practice and new drug development. (2006) (11)
- A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial (2014) (11)
- Characterization of the effect of the adenosine agonist cyclohexyladenosine on platelet activating factor-induced increases in [Ca2+]i in human platelets in vitro. (1990) (11)
- Toxic psychosis with cimetidine. (1979) (11)
- A double-blind comparison of thioridazine (Mellaril) versus diazepam (valium) in patients with chronic mixed anxiety and depressive symptoms. (1973) (10)
- Bipolar disorder and personality disorder (2003) (10)
- An exploratory study of responses to low-dose lithium in African Americans and Hispanics. (2015) (10)
- Mania in Children and Adolescents: Recognition and Treatment (1996) (10)
- Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania (2013) (10)
- Clinical utility of salivary lithium concentration. (1982) (10)
- Changes in urinary catecholamines and their metabolites in depressed patients treated with amitriptyline or imipramine. (1987) (10)
- The role of ziprasidone in adjunctive use with lithium or valproate in maintenance treatment of bipolar disorder (2011) (9)
- The International Society of Bipolar Disorders (ISBD) task force on the nomenclature of course and outcome in bipolar disorders (2010) (9)
- Can the Effects of Antidepressants Be Observed in the First Two Weeks of Treatment? (1997) (9)
- Factors associated with single versus multiple suicide attempts in depressive disorders. (2020) (9)
- Resolution of palinopsia with carbamazepine. (1997) (9)
- The Role of Divalproex in the Treatment of Bipolar Disorder (2002) (9)
- Analysis of bipolar maintenance treatment with lithium versus olanzapine utilizing Multi‐state Outcome Analysis of Treatments (MOAT) (2016) (9)
- Clinical trial design challenges in mood disorders (2015) (9)
- Bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study. (2017) (9)
- Studies of Catecholamine Metabolism in Schizophrenia/Psychosis-II (1993) (8)
- A course on behavioral skills and the psychological aspects of dentistry. (1975) (8)
- Relationships between recurrence and polarity in major depressive disorders: Pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts. (2019) (8)
- Lamotrigine Combined with Divalproex or Lithium for Bipolar Disorder: A Case Series (2006) (8)
- Determinants of initial use of opioids. (1971) (8)
- Biodevelopmental aspects of conduct disorder in boys (1993) (8)
- A-B THERAPIST VARIABLE AND PSYCHOTHERAPEUTIC OUTCOME (1972) (8)
- "Do depressive and manic symptoms differentially impact on functioning in acute depression? Results from a large, cross-sectional study". (2020) (8)
- Nonsteroidal anti‐inflammatory drugs (NSAIDs) and paracetamol do not affect 6‐month mood‐stabilizing treatment outcome among 482 patients with bipolar disorder (2017) (8)
- Open-Label, Concomitant Use of Lamotrigine and Other Medications for Bipolar Disorder (2008) (8)
- Prevalence and Characteristics of Undiagnosed Bipolar Disorders in Patients With a Major Depressive Episode (2011) (8)
- The biopsychosocial approach to the patient (1982) (7)
- ‘Delay’ hypothesis of onset of antidepressant action (2006) (7)
- Mania: gender, transmitter function, and response to treatment (1999) (7)
- Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response. (1997) (7)
- Familial severe psychiatric history in bipolar disorder and correlation with disease severity and treatment response. (2020) (7)
- Amitriptyline and nortriptyline response profiles in unipolar depressed patients (2004) (7)
- Lamotrigine delays mood episodes in recently depressed bipolar I patients (2002) (7)
- Characterization of rapid cycling bipolar patients presenting with major depressive episode within the BRIDGE‐II‐MIX study (2020) (7)
- The role of different patterns of psychomotor symptoms in major depressive episode: Pooled analysis of the BRIDGE and BRIDGE‐II‐MIX cohorts (2019) (7)
- Psychosocial basis of medical practice;: An introduction to human behavior (1974) (7)
- NOREPINEPHRINE OUTPUT AND METABOLISM IN DEPRESSED PATIENTS DURING ANTIDEPRESSANT TREATMENTS (1992) (7)
- Focus on bipolar disorder treatment. (2005) (6)
- Treatment outcomes of acute bipolar depressive episode with psychosis (2018) (6)
- Double-blind placebo-controlled trial of ketazolam in anxiety (1978) (6)
- The use of antidepressants in bipolar disorder patients with depression (2016) (6)
- Lamotrigine or lithium in the maintenance treatment of bipolar I disorder (2002) (6)
- Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trials. (2014) (6)
- Single-dose prediction of amitriptyline and nortriptyline requirement in unipolar depression (1980) (6)
- Increase in human urine homovanillic acid concentration after neuroleptic treatment is the same with or without debrisoquin administration. (1987) (6)
- Bipolar rapid cycling (2001) (6)
- Diagnosis of Bipolar Disorder (2005) (6)
- E.04.02 The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines (2009) (6)
- Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study. (2016) (6)
- Deconstructing major depressive episodes across unipolar and bipolar depression by severity and duration: a cross-diagnostic cluster analysis on a large, international, observational study (2020) (6)
- Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trials (2020) (5)
- The Clinical Approach to the Differential Diagnosis of Bipolar Disorder (1993) (5)
- Use of treatment services in a comparative effectiveness study of bipolar disorder. (2013) (5)
- Current treatment of depression. (1985) (5)
- Diagnosis and impact of bipolar depression. (2009) (5)
- Lithium-responsive depression. (1978) (5)
- Suicidal Ideation and Pharmacotherapy Among STEP-BD Patients (2006) (5)
- Comorbidities with Bipolar Disorders: Significance, Recognition, and Management (2010) (5)
- Concepts surrounding the diagnosis and treatment of mixed states in bipolar disorders (2005) (5)
- Monoamine oxidase and homovanillic acid in boys with predispositions to substance abuse. (1994) (5)
- S.22.02 Long-term prophylactic treatment priorities in bipolar disorder (1997) (5)
- Diagnosis of bipolar disorders: focus on bipolar disorder I and bipolar disorder II. (2002) (5)
- The anti-aging effects of lithium in lymphoblastoid cell lines from patients with bipolar disorder and controls. (2020) (5)
- Pharmacotherapy and risk of suicidal behaviors among patients with bipolar disorder. (2004) (5)
- Treatment strategies for bipolar depression. (2010) (5)
- Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment response. (2021) (4)
- Neuroleptic radioreceptor activity and clinical outcome in schizophrenia. (1987) (4)
- Childhood trauma and treatment outcomes during mood‐stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder (2022) (4)
- Binding of imipramine to platelet membranes is lower in alcoholics than in controls. (1987) (4)
- The componential approach enhances the effectiveness of 2-week trials for new antidepressants. (2011) (4)
- A video method for the evaluation of antidepressant clinical and behavioural actions. (2006) (4)
- WFSB task force on treatment guidelines for bipolar disorders. Part 1: treatment of bipolar depression (2002) (4)
- Introduction: the role of anticonvulsants as mood stabilizers. (2001) (4)
- Patterns of changes in bipolar depressive symptoms revealed by trajectory analysis among 482 patients with bipolar disorder (2018) (4)
- The authors reply [4] (2007) (4)
- Introduction: the use of mood stabilizers in the treatment of psychiatric disorders. (1999) (4)
- Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: clinical and methodological implications. (2013) (4)
- An Open Trial of Iloperidone for Mixed Episodes in Bipolar Disorder (2017) (3)
- Mania from dexfenfluramine. (1997) (3)
- Lamictal Monotherapy in the treatment of bipolar disorder (1997) (3)
- Investigating symptom domains of bipolar disorder for Spanish-speakers using the Bipolar Inventory of Symptoms Scale. (2016) (3)
- The human platelet as a model for calcium metabolism in central nerve endings in the study of alcoholism. (1987) (3)
- Plasma GABA predicts response to divalproex in mania (1995) (3)
- Psychopharmacological treatment of panic disorder. (1992) (3)
- Relationship of acute mania symptomatology to maintenance treatment response (2004) (3)
- In Reply: Efficacy of Divalproex vs Lithium and Placebo in Mania (1994) (3)
- Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials (2019) (3)
- A US perspective of the CANMAT bipolar guidelines. (2005) (3)
- Sequential Multiple Assignment Randomized Treatment (SMART) for Bipolar Disorder at Any Phase of Illness and at least Mild Symptom Severity. (2020) (3)
- The effect of debrisoquin on MAO A and MAO B activities. (1989) (3)
- Community psychiatry: Scott County evaluation. (1972) (2)
- Moving the Field Forward 09 : 0010 : 30 THE INTERNATIONAL SOCIETY OF BIPOLAR DISORDERS TASK FORCE ON THE NOMENCLATURE OF COURSE AND OUTCOME IN BIPOLAR DISORDERS (2007) (2)
- Inhibition by lithium differentiates CaATPase and CaMgATPase activities in human platelet membranes (1984) (2)
- Improving identification of treatment effectiveness in bipolar disorders. (2003) (2)
- Valproate: Clinical Pharmacological Profile (2006) (2)
- Psychosocial basis of health care (1983) (2)
- Bipolar disorders: treatment options and patient satisfaction (2006) (2)
- Clinical management of anxiety. (1990) (2)
- A Biopsychosocial Model for Psychiatry (1980) (2)
- P.1.210 Concomitant use of lamotrigine and valproate in bipolar I disorder (2003) (2)
- EGTA-extractable calmodulin in platelet membrane is lower in alcoholics than in controls. (1985) (2)
- Path analysis of psychopharmacological data: Catecholamine breakdown in man (1986) (2)
- Lithium plus antipsychotics or anticonvulsants for bipolar disorder: Comparing clinical response and metabolic changes (2022) (2)
- Introduction: the burden of bipolar depression. (2005) (2)
- Psychopharmacology for Primary Care Physicians (1987) (2)
- P.1.133 Lamictal® monotherapy in the treatment of bipolar disorder (1997) (2)
- "A two-illness model of bipolar disorder"--by RT Joffe, LT Young, and GM MacQueen: a commentary. (1999) (1)
- Does calmodulin (CM) regulate CaATPase activity in dense tubular system and plasma membranes of human platelets (1985) (1)
- Tranylcypromine and Inhibition of MAO Activity (1984) (1)
- Hypomanic symptoms in mixed depression – is DSM-5 wrong? Evidence from the BRIDGE-II-MIX study (2016) (1)
- Valproate and mood disorders: perspectives. Introduction. (1992) (1)
- Treatment of Depression: Old Controversies and New Approaches—edited by Paula J. Clayton, M.D., and James E. Barrett, M.D.; Raven Press, New York, 1983, 338 pages, $52.50 (1984) (1)
- Characteristics of patients with bipolar disorder presenting a current major depressive episode: Analysis in eight countries (2010) (1)
- Pharmacological treatments for bipolar disorder: present recommendations and future prospects. (2011) (1)
- Treatment of rapid cycling bipolar disorder (2002) (1)
- Investigation of Epigenetic Aging in Bipolar Disorder and the In Vitro Anti-Aging Effects of Lithium (2020) (1)
- Classic Mania: Treatment Response to Divalproex or Lithium—Reply (1998) (1)
- 13th National Congress of the South African Society of Psychiatrists, 20-23 September 2004 (2004) (1)
- Challenges in clinical practice (1997) (1)
- Original Article A Randomized, Placebo-Controlled 12-Month Trial of Divalproex and Lithium in Treatment of Outpatients With Bipolar I Disorder (2019) (1)
- MHPG AS A PREDICTOR OF CLINICAL RESPONSE TO FLUOXETINE (1992) (1)
- Lithium levels in bodily fluids of a nursing mother and infant (1990) (1)
- Cognitive therapy is more cost effective than standard care alone for bipolar disorder (2006) (1)
- Lamotrigine in bipolar depression and rapid cycling (2001) (1)
- Acute effects of neuroleptics on unmedicated schizophrenics and controls (1993) (1)
- Common sources of disparate results and experience in clinical practice vs. results from phase 2 registration studies: lamotrigine as a prototype (2015) (1)
- C.17.02 Valproate in mania: from Pierre Lambert to New Deli Study (2006) (1)
- Erratum: "Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar i or II disorder: Results from the bipolar CHOICE trial" [Journal of Affective Disorders (2014) 161 (30-35)] (2014) (1)
- Sequential Multiple Assignment Randomized Treatment (SMART) (2015) (1)
- A study about late age onset depression. (2001) (1)
- P.2.e.01l Characteristics of patients with bipolar disorder presenting a current major depressive episode: analysis in 8 countries (2009) (1)
- Dr. Goldberg replies (American Journal of Psychiatry (February 2008) 165 (264)) (2008) (1)
- Expand the applicability and acceptability of CBT approaches in mood disorders (2014) (1)
- Dosing of divalproex extended release. Author's reply (2007) (1)
- The effects of lithium and lamotrigine in prevention of relapse/recurrence of bipolar I depression (2004) (1)
- Risperidone plus mood stabilizer versus placebo plus mood stabilizer in patients with bipolar disorder: A combined efficacy analysis (2001) (1)
- The presence of Alzheimer's disease in a community population. (1990) (1)
- Managing Bipolar Depression (2004) (1)
- Evidence-based efforts to re-define bipolar disorders (2011) (1)
- The effect of sodium on the bioavailability of lithium (1979) (1)
- Adjunctive risperidone in acute mania: A combined efficacy analysis (2001) (1)
- P.1.213 Safety and tolerability of lamotrigine in bipolar I disorder (2003) (1)
- BRIDGE Study Warrants Critique-Reply. (2012) (1)
- Dr. Bowden replies [3] (2007) (0)
- Calcium-stimulated (+Mg++/-Mg++ ATPase activity in a human platelet membrane fraction: Inhibition by fluphenazine (1982) (0)
- Developing new treatments for bipolar disorder: Dr. Bowden replies (2010) (0)
- Dr.Goldberg replies (vol 165, pg 264, 2008) (2008) (0)
- Corrigendum to bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study [Journal of Affective Disorders 217 (2017) 183-189]. (2018) (0)
- Oral topiramate was effective as an adjunct to standardised medication compliance management in alcohol dependence (2004) (0)
- P.3.e.014 VALID: a 12-week, open, randomised trial of valproate and lithium in bipolar I patients suffering from a manic episode (2007) (0)
- Erratum: (Expert Opinion on Pharmacotherapy)) (2002) (0)
- Grand Rounds Teaching Monograph: Current Treatments in Bipolar Disorder (1998) (0)
- Bibliography for Bipolar Disorder (2003) (0)
- The Burden of Bipolar Depression (2005) (0)
- NEUROCHEMICAL SUBTYPES FOR PREDICTION OF DRUG RESPONSE (1984) (0)
- C.04.03 Treating the whole patient: understanding the complexities of bipolar disorder (2009) (0)
- Introduction: Long-Term Use of Mood Stabilizers in Bipolar Disorder (2002) (0)
- Platelet serotonin (5HT) content is higher in alcoholics at three time points after beginning abstinence than in controls (1989) (0)
- Benzodiazepines: A 1990 update. Roundtable discussion (1990) (0)
- Advances on prophylactics of bipolar disorder (1998) (0)
- Introduction (1992) (0)
- Improving management of psychiatric patients in an emergency room (1980) (0)
- Perspective for new pharmacological interventions (2016) (0)
- Frantz Fanon: His Power (1971) (0)
- 'Delay' hypothesis of onset of antidepressant action. Author's reply (2006) (0)
- Introduction: managing bipolar depression. (2004) (0)
- EFFECTS OF FLUOXETINE AND DESIPRAMINE ON URINARY CATECHOLAMINE AND METABOLITE EXCRETION IN MAJOR DEPRESSION (1992) (0)
- P.2.e.018 Frequency of mixed states in patients with a major depressive episode:the BRIDGE MIX study (2010) (0)
- Divalproex did not differ from placebo or lithium in preventing recurrence of new mood episodes in bipolar I disorder, remission phase (2001) (0)
- P.1.214 Lamotrigine controls bipolar depression without destabilising mood: An analysis of data from 8 placebo-controlled trials (2003) (0)
- Recent maintenance research in bipolar I disorder (2002) (0)
- The role of anticonvulsants as mood stabilizers (2001) (0)
- Use of risperidone in psychotic and non-psychotic patients with bipolar disorder (2000) (0)
- Catecholamine metabolism in psychotic/schizophrenic patients (1991) (0)
- Span apprehension in schizophrenia: Relation to behavioral ratings, negative symptoms, and neurochemistry (1995) (0)
- Platelet mao and cortisol activity in depression (1989) (0)
- Multistate Outcome and Persistent Benefit Analysis in Bipolar Mood Disorders (2018) (0)
- New developments in the treatment of anxiety disorders. (1988) (0)
- Chapter Seven – Sequential Multiple Assignment Randomized Treatment (SMART): Designs in Bipolar Disorder Clinical Trials (2015) (0)
- Editorial comment: Low valproate use influenced by period of study (2001) (0)
- Managing Depression in the '70s (1975) (0)
- The Role of Antiepileptic Drugs in Long-Term Treatment of Bipolar Disorder (2008) (0)
- Recent advances in the benzodiazepines. (1979) (0)
- Evidence for Shortening the Duration of Clinical Trials of Antidepressants and a Proposed Paradigm for Such Studies (2015) (0)
- Treatment pathways for bipolar disorder in the USA and Europe: convergence or divergence? (2003) (0)
- P.1.217 Predictors of response to lithium and lamotrigine prophylaxis in bipolar I disorder (2003) (0)
- Prevention of Mania and Maintenance Treatment in Bipolar Disorder (2009) (0)
- Deadly Sins/Measured Virtues (2006) (0)
- SUBTYPES OF DEPRESSION AND RESPONSE TO TRICYCLIC DRUGS (1984) (0)
- Risperidone treatment for acute mania: assessment of tolerability (2000) (0)
- Erratum: Relationship between serum valproate and lithium levels and efficacy and tolerability in bipolar maintenance therapy (International Journal of Psychiatry in Clinical Practice (2005) 9,4 (271-277)) (2006) (0)
- Dr. Bowden Replies (1981) (0)
- Neurotransmitter systems function in schizophrenia/psychosis (1989) (0)
- P.2.e.016 Sensitivity of a comprehensive rating scale for bipolar disorders to assess improvements with treatment (2009) (0)
- Providing assessable information on effectiveness of maintenance treatments for bipolar disorder to psychiatrists and patients (2015) (0)
- INTERNAL ADVISORY BOARD OFFICE OF THE VICE PRESIDENT FOR RESEARCH (2006) (0)
- Lamotrigine and lithium as maintenance treatment for bipolar I disorder (2004) (0)
- Non-specific neuroleptic isomer effect on calmodulin-stimulated calcium transport in erythrocyte membrane (1985) (0)
- EFFECTS OF FLUOXETINE & DESIPRAMINE ON PLATELET IMIPRAMINE BINDING IN MAJOR DEPRESSION (1992) (0)
- P.3.e.013 The utility of oral loading dose strategies in the treatment of acute mania with valproate (2007) (0)
- Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder. (2021) (0)
- Bibliography B IPOLAR D ISORDER (2011) (0)
- The use of mood stabilizers in the treatment of psychiatric disorders (1999) (0)
- Visual-perceptual disturbances in delusional misidentification. (1995) (0)
- Design of clinical trials in bipolar disorders (2012) (0)
- S-36-3 New concepts in mood stabilization: Evidence for the effectiveness of valproate and lamotrigine (1996) (0)
- Abstracts from the 3rd Biennial Conference of the International Society for Bipolar Disorders. January 27-28, 2008. Delhi, India. January 30, 2008. Agra, India. (2008) (0)
- Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-response (2021) (0)
- Suicidal Ideation and Pharmacotherapy STEP-BD (2006) (0)
- P.3.a.030 A 6-month, double-blind trial of ziprasidone plus a mood stabilizer in subjects with bipolar I disorder (2009) (0)
- Help Your Bipolar Disorder Patients Remain Employed: Integrate Work-Related Issues as You Address Symptoms, Medication, and Function (2009) (0)
- Novel treatments for bipolar disorder (Expert Opinion on Investigational Drugs (2001) vol. 10 (4) (661-915)) (2001) (0)
- A new catecholamine hypothesis (1989) (0)
- Erratum: Recognizing the needs of bipolar patients with comorbid psychiatric conditions (Psychiatric Times (2007)) (2007) (0)
- Improving criteria for differentiating bipolar disorder and major depressive disorder in patients experiencing a major depressive episode (2012) (0)
- manic or mixed episodes Influence of sub-syndromal symptoms after remission from (2011) (0)
- CHOICE ) : A pragmatic trial of complex treatment for a complex disorder Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (2013) (0)
- P.2.e.022 Does shorter vs. longer stabilisation in patients with bipolar I disorder predict relapse? (2011) (0)
- Reply (1999) (0)
- Mania associated with high percentage of inhibition of monoamine oxidase. (1989) (0)
- P.1.212 Effects of lithium and lamotrigine on body weight after 18 months in bipolar I disorder (2003) (0)
- Maintenance treatment in bipolar disorder (2003) (0)
- Affective Disorders Circa 1983 (1983) (0)
- The function and organization of NIMH. (1977) (0)
- Reply to Dosing of Divalproex Extended Release (2007) (0)
- Circadian gene polymorphisms and liability to bipolar I disorder (2007) (0)
- C.15.03 Bipolar disorder: optimal management strategies (2007) (0)
- Lithium Treatment Moderate-Dose Use Study (LiTMUS) for Bipolar Disorder: A Randomized Comparative Effectiveness Trial of Optimized Personalized Treatment With and Without Lithium (2015) (0)
- Safety and Tolerability Associated with Second Generation Antipsychotic Polytherapy in Bipolar Disorder: Findings from STEP-BD (2009) (0)
- P.1.216 Lamotrigine but not lithium prevents or delays depressive episodes in bipolar I disorder (2003) (0)
- The effect of lithium on the thrombin-induced 5-hydroxytryptamine release of human platelets in controls and subjects with affective disorders: A preliminary report (1989) (0)
- A-B THERAPIST VARIABLE: REPLY TO BETZ'S AND WHITEHORN'S COMMENTARIES (1972) (0)
- Reviewers for The American Journal of Psychiatry. (2015) (0)
- Therapeutics seminar: a practical guide to anxiety and depression (1973) (0)
- Psychotropics and glaucoma. (1977) (0)
- Cognitive Dysfunction in Bipolar Disorder: A Guide for Cliniciansedited by Goldberg Joseph F. and Burdick Katherine E. . Foreword by Goodwin Frederick K. . Washington, D.C. American Psychiatric Publishing, Inc. , 2008 , 316 pp., $45.00. (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Charles L. Bowden?
Charles L. Bowden is affiliated with the following schools:
